TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
OCUL holding history
Ocular Therapeutix, Inc in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,647,752
- Value
- $16.2M
- % of portfolio
- 0.4%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,647,752 | $16.2M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,647,752 | $14.0M | 0.4% | −4,092,479−71.3% | Reduced | Holders |
| Q4 2025 | 5,740,231 | $69.7M | 2.3% | −377,001−6.2% | Reduced | Holders |
| Q3 2025 | 6,117,232 | $71.5M | 3.5% | +798,084+15.0% | Added | Holders |
| Q2 2025 | 5,319,148 | $49.4M | 5.6% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,319,148 | $39.0M | 5.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 5,319,148 | $45.4M | 4.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 5,319,148 | $46.3M | 3.9% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5,319,148 | $36.4M | 3.8% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5,319,148 | $48.4M | 3.8% | +5,319,148 | New | Holders |